๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Icam-1 polymorphism: New risk factor for hepatocellular carcinoma in patients with chronic hepatitis C?

โœ Scribed by P.K. Constantini; M. Egg; I.W. Graziadei; W. Vogel

Book ID
119526023
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
141 KB
Volume
32
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hepatic steatosis is a risk factor for h
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
โœ Kazuyuki Ohata; Keisuke Hamasaki; Kan Toriyama; Kojiro Matsumoto; Akira Saeki; K ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 102 KB ๐Ÿ‘ 3 views

## Abstract ## BACKGROUND Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of

Risk factors for hepatocellular carcinom
Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
โœ Akinori Kasahara; Norio Hayashi; Kiyoshi Mochizuki; Masahide Takayanagi; Kentaro ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 112 KB ๐Ÿ‘ 2 views

To elucidate the risk factors for liver carcinogenesis and to examine the incidence of hepatocellular carcinoma (HCC) after interferon therapy, 1,022 chronic hepatitis C patients treated with interferon were followed by ultrasonography for 13 to 97 months (median 36 months). Sustained response with